Table 3.
Time points | Vitamin D status |
p value |
||||
---|---|---|---|---|---|---|
Deficient <50 nmol/L (n = 23) | Insufficient 50–75 nmol/L (n = 32) | Sufficient >75 nmol/L (n = 32) | vitamin D*time | vitamin D | time | |
HGS, kg | 0.482 | 0.322 | 0.143 | |||
T0 | 23.4±2.14 | 26.2±1.57 | 25.7±1.74 | |||
T1 | 23.3±1.89 | 27.8±1.33 | 25.2±1.50 | |||
T2 | 24.7±2.07 | 28.2±1.43 | 26.4±1.63 | |||
T4 | 26.0±2.13 | 27.1±1.60 | 25.7±1.76 | |||
CST, s | 0.411 | 0.836 | 0.010c | |||
T0 | 32.4±3.45 | 33.6±2.50 | 28.6±2.76 | |||
T3 | 28.3±2.97 | 29.8±1.91 | 29.4±2.17 | |||
T4 | 25.6±3.20 | 25.6±2.06 | 27.0±2.26 | |||
TUG, s | 0.426 | 0.574 | <0.001c, d | |||
T0 | 12.1±0.89 | 11.8±0.73 | 11.0±0.75 | |||
T3 | 12.1±0.88 | 11.4±0.57 | 12.7±0.65 | |||
T4 | 10.4±0.72 | 9.6±0.45 | 10.2±0.50 | |||
10MWT, s | 0.485 | 0.342 | <0.001c, d | |||
T0 | 12.6±1.23 | 11.0±0.98 | 10.0±1.03 | |||
T3 | 10.0±0.67 | 9.6±0.40 | 10.0±0.46 | |||
T4 | 9.1±0.63 | 8.1±0.38 | 8.6±0.42 | |||
LAPAQ, min/day | 0.896 | 0.021a | <0.001b, c, d | |||
T0 | 80.2±25.85 | 143.7±19.82 | 108.1±20.86 | |||
T3 | 22.1±16.18 | 57.2±9.70 | 28.4±11.64 | |||
T4 | 58.1±17.80 | 92.9±11.52 | 62.3±12.89 | |||
WOMAC, scale 0–96 | 0.910 | 0.559 | <0.001b, c | |||
T0 | 40.3±4.01 | 42.5±2.99 | 42.8±3.17 | |||
T3 | 4.9±3.64 | 10.1±1.90 | 8.9±2.37 | |||
T4 | 3.6±4.50 | 6.3±2.19 | 7.4±2.55 |
Values are presented as mean ± SEM.
Linear mixed model analysis, adjusted for gender, age, BMI, length of hospital stay and the need for physiotherapy.
THA, total hip arthroplasty; HGS, hand grip strength; CST, chair stand test; TUG, timed up and go test; 10MWT, 10-meter walking test; LAPAQ, LASA Physical Activity Questionnaire; WOMAC, Western Ontario and McMaster Universities Osteoarthritis index. Posthoc analyses, corrected for multiple comparison with Bonferroni:
p < 0.05, deficient vs insufficient
p < 0.001, T0 vs. T3
p < 0.01, T0 vs. T4
p < 0.001, T3 vs. T4.